Quality of Life of Patients with Hypertension and Treatment Compliance

摘要

Background The research was held within the framework of the program “Correction of the components of the metabolic syndrome by the method of biofeedback”. Method The study involved 90 patients, specifically 33 men and 57 women with Stages 1–3 hypertension as well as 25 healthy persons who live in various districts of Karaganda and are monitored on outpatient basis. We used analysis of variance, namely Fisher’s exact test, to gauge statistically significant differences in quality of life between the groups of treatment. Results The results of survey using questionnaire SF-36 showed that while hypertension leads to the statistically significant reduction of all components of quality of life, three of the components - PF; RP and BP - are statistically significantly reduced in case of patient's low or no compliance with treatment. Conclusion The research suggests that antihypertensive therapy as a whole is noted for a low level of compliance. This, in turn, leads to insufficient control of arterial hypertension and results in a decrease in quality of life.